Document is current
Any future updates will be listed below
-
Authors
Haupt, Robert
Baracco, Lauren
Harberts, Erin M.
Loganathan, Madhumathi
Kerstetter, Lucas J.
Krammer, Florian
Coughlan, Lynda
Ernst, Robert K.
Frieman, Matthew B.
-
Funding
Funding for this research was provided by:
Biomedical Advanced Research and Development Authority (ASPR-20-01495)
National Institutes of Health (75N93019C00051, R21AI146529)
U.S. Army’s Long Term Health and Education Training Program
National Institute of Allergy and Infectious Diseases (75N93019C00051)
- License Information
-
More Information
Article History
Received: 10 October 2022
Accepted: 10 January 2023
First Online: 13 January 2023
Competing interests
: The Icahn School of Medicine at Mount Sinai has filed patent applications regarding influenza virus vaccines which list FK as inventor. In addition, FK is currently consulting for Pfizer, Third Rock Ventures and Avimex. MF received royalties/licenses from Aikido Pharma for antiviral drug patent licensing, consulting fees from Aikido Pharma, Observatory Group, for consulting for COVID-19, and participation on Scientific Advisory Board for Aikido Pharma, outside the submitted work. All other authors declare no competing interests.
